Statement of Principles concerning von Willebrand disease (Reasonable Hypothesis) (No. 45 of 2023)

Administered by Department of Veterans' Affairs

Legislation au F2023L00512 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

VON WILLEBRAND DISEASE

(REASONABLE HYPOTHESIS) (NO. 45 OF 2023)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning von Willebrand disease  (Reasonable Hypothesis) (No. 45 of 2023).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 41 of 2015 (Federal Register of Legislation No. F2015L00006) determined under subsection 196B(2) of the VEA concerning von Willebrand disease .

3.             The Authority is of the view that there is sound medical-scientific evidence that indicates that von Willebrand disease  and death from von Willebrand disease  can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles concerning von Willebrand disease  (Reasonable Hypothesis) (No. 45 of 2023).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting von Willebrand disease  or death from von Willebrand disease , with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 10 MAY 2022 concerning von Willebrand disease  in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'von Willebrand disease' in subsection 7(2);
  • including ICD-10-AM codes for 'von Willebrand disease ' in subsection 7(3);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);

 

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to von Willebrand disease  in the Government Notices Gazette of 10 MAY 2022, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this Instrument finalises the investigation in relation to von Willebrand disease  as advertised in the Government Notices Gazette of 10 MAY 2022.

References

11.         A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 45 of 2023

Kind of Injury, Disease or Death: Von Willebrand disease

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have von Willebrand disease ;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting von Willebrand disease  with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 41 of 2015; and
  • reflects developments in the available sound medical-scientific evidence concerning von Willebrand disease  which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning von Willebrand disease (Reasonable Hypothesis) (No. 45 of 2023) was enacted to address the issue of providing medical and compensation benefits to veterans and Defence Force members suffering from von Willebrand disease, a genetic disorder affecting blood clotting. The Repatriation Medical Authority, under the authority granted by subsection 196B(8) of the Veterans' Entitlements Act 1986 (VEA), repealed the previous Instrument No. 41 of 2015 concerning von Willebrand disease and determined this new Statement of Principles to reflect the latest medical-scientific evidence. This legislative instrument sets out the minimum factors that must exist to establish a reasonable hypothesis connecting von Willebrand disease with specific types of service, facilitating the assessment and approval of claims under both the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). The Authority undertook an investigation into von Willebrand disease and published its intention to investigate in the Government Notices Gazette, inviting submissions from relevant parties, though none were received. The Statement of Principles is compatible with human rights as recognised by international instruments, promoting rights such as social security, an adequate standard of living, and health, without discrimination.

Scope and Application

The Statement of Principles concerning von Willebrand disease (Reasonable Hypothesis) (No. 45 of 2023) applies to veterans, current and former Defence Force members, and their dependents, and is intended to facilitate the determination of claims for medical treatment and compensation under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This Statement of Principles outlines the specific factors that must be present and related to particular kinds of service, including operational, peacekeeping, hazardous, and warlike service, to establish a reasonable hypothesis connecting von Willebrand disease or death from von Willebrand disease with the circumstances of that service. This legislative instrument has national jurisdictional reach, applicable across Australia. The Statement of Principles does not specify any exclusions or exemptions but is contingent upon the availability of sound medical-scientific evidence. Subordinate instruments may extend or restrict the application of this Act, reflecting advancements in medical-scientific evidence.

Key Provisions

The Statement of Principles concerning von Willebrand disease (Reasonable Hypothesis) (No. 45 of 2023) serves to outline the factors that must exist to establish a connection between von Willebrand disease, death from this condition, and particular types of service (Section 5). This instrument applies to claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The key types of service in question include operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, as well as warlike and non-warlike service under the MRCA. The Statement of Principles sets out the minimum factors required to raise a reasonable hypothesis connecting von Willebrand disease or death from it with the circumstances of the service rendered (Section 5). The obligations imposed by this Act primarily concern the Repatriation Medical Authority (the Authority), which must ensure that claims related to von Willebrand disease are assessed based on the sound medical-scientific evidence available. The Authority is responsible for determining the Statement of Principles and ensuring that it is compatible with human rights, as well as facilitating the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal (Sections 4 and 9). Furthermore, the Authority must replace any previous instruments that are repealed, as seen with Instrument No. 41 of 2015 (Section 2). In terms of consequences for breach, the legislation does not explicitly outline specific offences, penalties, or consequences for non-compliance. However, the importance of adhering to the sound medical-scientific evidence and human rights principles suggests that any significant deviation could result in legal challenges or reviews. The Authority's role in ensuring the compatibility of the instrument with human rights also implies that any failure to do so might lead to scrutiny and potential legal ramifications. The emphasis on the medico-scientific quality of outcomes indicates that any breaches could undermine the integrity of the claims process and the benefits extended to eligible persons.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Offence Provisions
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.